Synthesis of (R)-Rasagiline via Dynamic Kinetic Resolution
Significance: Rasagiline mesylate (Azilect®) is a selective monoamine oxidase B inhibitor that is administered as initial monotherapy in early Parkinson's disease and as adjunct therapy to levodopa in moderate-to-advanced disease. The key step in the synthesis depicted is the dynamic kinetic resolution of racemic 1-aminoindan A catalyzed by immobilized Candida antarctica lipase B (CALB) together with a palladium racemization catalyst -a process that could be conducted in a concentration of up to 200 g/L.
Comment: The palladium nanocatalyst Pd/ AlO(OH) racemizes the amine via an imine intermediate (hydrogen borrowing). Racemization was complete in four hours using only 0.5 mol% of palladium in toluene at 70 °C. The catalyst was prepared as palladium nanoparticles entrapped in aluminum hydroxide according to the procedure of Y. Kim et al. (Tetrahedron Lett. 2010, 51, 5581) . The chemoenzymatic catalyst system could be recycled 5-6 times. This document was downloaded for personal use only. Unauthorized distribution is strictly prohibited.
